Within the current study, we confirm that treatment of cancer cell lines with the cMET inhibitor INC280 significantly impairs HGF-induced growth and motility of tumour cells, at least in part via inhibition of Akt, ERK and FAK phosphorylation. The gene discussed is PTK2; the disease is cancer.